Identify Effective Doses of LY01021 in Controlled Ovarian Hyperstimulation (COH) for Female Subjects Undergoing Assisted Reproductive Technology (ART)
Clinical trial NCT07236476 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07236476
- Sponsor
- Luye Pharma Group Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-09
- Primary completion
- 2025-12-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.